ADC Therapeutics S.A.
Records under this name other than the patents ADC Therapeutics S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 11 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,736,903 | Pyrrolobenzodiazepine-Anti-Psma Antibody Conjugates Formerly held In force · High confidence | In force | High confidence | |
| US 10,780,181 | Pyrrolobenzodiazepine-Antibody Conjugates Formerly held In force · High confidence | In force | High confidence | |
| US 10,799,596 | Pyrrolobenzodiazepine-Antibody Conjugates Formerly held In force · High confidence | In force | High confidence | |
| US 11,771,775 | Pyrrolobenzodiazepine-Antibody Conjugates Formerly held In force · High confidence | In force | High confidence | |
| US 11,779,650 | Pyrrolobenzodiazepine-Antibody Conjugates Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,950,078 | Pyrrolobenzodiazepine-Antibody Conjugates Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,931,414 | Pyrrolobenzodiazepine-Antibody Conjugates Formerly held In force · High confidence | In force | High confidence | |
| US 11,059,893 | Humanized anti-AXL antibodies Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,544,223 | Combination Therapy with an Anti-Axl Antibody-Drug Conjugate Formerly held In force · High confidence | In force | High confidence | |
| US 11,813,335 | Pyrrolobenzodiazepine-Antibody Conjugates Formerly held In force · High confidence | In force | High confidence |